Gilbert & Cook, Inc.
- SEC CIK
- 0001675762
- Latest filing
- Jul 28, 2026
ALNY holding history
Alnylam Pharmaceuticals, Inc. in every 13F filed by Gilbert & Cook, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ALNY overviewAll 13F holders of ALNYFull Q2 2026 holdings
- Shares (Q2 2026)
- 3,928
- Value
- $1.18M
- % of portfolio
- 0.1%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 3,928 | $1.18M | 0.1% | −32−0.8% | Reduced | Holders |
| Q1 2026 | 3,960 | $1.31M | 0.2% | −58−1.4% | Reduced | Holders |
| Q4 2025 | 4,018 | $1.60M | 0.2% | −1,490−27.1% | Reduced | Holders |
| Q3 2025 | 5,508 | $2.51M | 0.3% | +1,514+37.9% | Added | Holders |
| Q2 2025 | 3,994 | $1.30M | 0.2% | +90+2.3% | Added | Holders |
| Q1 2025 | 3,904 | $1.05M | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2024 | 3,904 | $918.6K | 0.1% | −20−0.5% | Reduced | Holders |
| Q3 2024 | 3,924 | $1.08M | 0.1% | −137−3.4% | Reduced | Holders |
| Q2 2024 | 4,061 | $986.8K | 0.1% | −424−9.5% | Reduced | Holders |
| Q1 2024 | 4,485 | $670.3K | 0.1% | +42+0.9% | Added | Holders |
| Q4 2023 | 4,443 | $850.4K | 0.1% | +317+7.7% | Added | Holders |
| Q3 2023 | 4,126 | $730.7K | 0.1% | +2,766+203.4% | Added | Holders |
| Q2 2023 | 1,360 | $258.3K | <0.1% | +1,360 | New | Holders |